Aim: Depression is often undiagnosed in primary care. Asking about sleep status is much easier than asking about mood. This study was conducted to examine the relation between insomnia and depression.
patients are affected by depression, 3, 4 making it a common disease.
The difficulty of recognizing depressive patients in the primary care setting was reported several decades ago. 5 Primary care physicians must look for many possible physical illnesses other than depression. Diagnosing new patients with depression at an initial medical consultation can be considerably difficult. Moreover, in one study, 79% of subjects with depression had experienced discrimination in daily life. 6 Approximately 8% of patients reported high stigma, stating that they would not accept a depression label from their physician. 7 Such stigma among patients may make it easier for physicians to inquire about sleep status than about depressive mood. Patients may also find it easier to respond to questions about insomnia than about mood problems.
That being the case, how should physicians ask about insomnia, length of sleep, difficulty falling asleep, or hypnotic medicines taken? Few studies have investigated the relation between detailed sleep-related questions and depression among primary care patients. Although there has been some investigation of this relation in different populations, [8] [9] [10] [11] [12] [13] as far as we know, this association has been investigated in the primary care setting only among elderly people. 14 Although there are investigations about screening for depression in primary care settings, 15, 16 careful investigation of sleep status to diagnose depression is rare. Therefore, this study was carried out to explore the relation between insomnia and depression in workinggeneration primary care patients aged 35-64 years.
METHODS

Study subjects
Study subjects were new patients aged 35-64 years recruited from three internal medicine clinics in Fuji, Shizuoka Prefecture, Japan from 10 May 2011 to 24 May 2012. New patients were defined as subjects visiting a clinic for the first time or who had not visited the clinic in over 6 months. Major ineligibility criteria were body temperature ≥ 37. 5 C, clear externally caused injury, visual impairment, or auditory difficulties because these conditions were considered likely to interfere with their ability to complete the questionnaires. At each clinic, eligible patients were consecutively asked to participate in the study. A total of 600 subjects, 200 from each clinic, were enrolled. The Ethics Committee of Kurume University approved the study protocol (10286). This study was conducted in accordance with the Declaration of Helsinki (October 2008). Written informed consent was obtained from all subjects before participation.
Information collection
Self-administered, structured questionnaires were given to patients, and a structured questionnaire was filled out by the consulting physicians. Physical and environmental information was obtained using selfadministered questionnaires completed by subjects at the time of enrolment before medical consultation. Questionnaire data were not shown to the patients' physicians to avoid influencing physician diagnoses.
The self-administered questionnaires gathered information about sex, age, height, weight, exercise habits, major life events, relationship problems in the workplace, family discord, amount of alcohol consumed, frequency of drinking alcohol, smoking history, educational background, occupation, type of employment, marital status, family history of psychiatric disorder, outpatient treatment of psychiatric illnesses, diagnosis of psychiatric disease, and past and present diagnosis of other underlying diseases (hospitalization history, regular outpatient treatment). Economic difficulty was investigated by a visual analogue scale (VAS) consisting of a 100-mm horizontal line, ranging from no difficulty to severe difficulty. In this study, VAS measurements from 0 to 19.9 mm, from 20 to 49.9 mm, and ≥50 mm were defined as little, moderate, and severe economic difficulty, respectively. Sleep status was assessed using the Pittsburgh Sleep Quality Index (PSQI). 17 Depressive symptoms were investigated using the Zung Self-Rating Depression Scale (SDS), [18] [19] [20] along with the Profile of Mood States (POMS). [21] [22] [23] The questionnaire for physicians collected information about diagnosis, chief complaints, prescriptions, and psychiatric consultations.
Definition of insomnia
We used the Japanese version of the PSQI, a selfadministered questionnaire, designed to assess quantitative and qualitative aspects of sleep during the previous month to assess insomnia. 17, 24 Individual items are combined to form seven separate scales or 'components' of sleep. The different component scores are summed to produce a global score between 0 and 21, where 0 indicates no difficulty and 21, severe difficulty. Those with global scores >5 are defined as poor sleepers, while those with scores ≤5 are good sleepers. 17, 25 The current study focused on the individual items as well as global scores. We also collected information on average length of sleep on weekdays, holidays, and the previous night.
Case definition
Subjects assessed to be in a depressed state by both the SDS and POMS were defined as having depression. We used the SDS translated into Japanese; this contains 20 items, scored from 1 to 4. The total score is multiplied by 1.25 to obtain the SDS index, which ranges from 25 to 100. An SDS index of 50 was used as a morbidity cut-off score. 19, 26 The POMS is a 65-item self-administered questionnaire scored from 0 (not at all) to 4 (extremely). [21] [22] [23] It is designed to examine six mood states: Tension-Anxiety, Depression-Dejection, Anger-Hostility, Fatigue, Confusion, and Vigor. The subscale of Depression was calculated from 15 items with a range of scores from 0 to 60. Reliability and validity of the Japanese version of the POMS have been reported by Yokoyama et al., with especially good reliability for Depression-Dejection. 22, 23 The mean plus the standard deviation of a so-called healthy adult population were used as cut-off scores for depressive mood state (cut-off scores are 18.3, 16.3, 16.9, and 13.7 for men and 17.4, 16.3, 14.2, and 12.8 for women aged 35-39, 40-49, 50-59, and ≥60, respectively). 23 As a secondary outcome, depression was defined by both a modified SDS and POMS. The modified SDS excluded two items ('I have trouble sleeping through the night' and 'I get tired for no reason') and was rescaled for comparability to the original 20-item SDS. 13 These two items were excluded to avoid overestimation of the association between insomnia and depression. Each subject's total score from the 18 items was divided by 18 and multiplied by 20, then multiplied by 1.25 to derive the modified SDS index.
Data analyses
Various characteristics of depressive and nondepressive subjects were compared using the χ 2 or Fisher's exact test. For continuous variables, the Wilcoxon rank-sum test was employed. Sensitivity, specificity, positive and negative predictive value, positive likelihood ratios (LR+) and negative likelihood ratios (LR−) of sleep-related symptoms were calculated. 27 To assess relationships between insomnia and depression independent of confounding factors, adjusted odds ratios (OR) and their 95% confidence intervals (95%CI) were calculated by logistic regression. All analyses except for likelihood ratios and their confidence intervals were conducted using SAS 9.4 (SAS Institute Inc., Cary, NC, USA). A P-value < 0.05 (two-sided) was considered significant.
Adjusted variables included in Model 1 were sex, age (as a continuous variable), marital status, type of employment, cigarette smoking, mean alcohol consumption per day, 28 major life events within the past 6 months (at least one), relationship problems, economic difficulty, history or recent treatment of mental disorder, nervous system disease, digestive disease, and diagnosis of common cold at medical consultation (Model 1). Further adjustments in Model 2 included medicines taken (prescribed or over-the-counter hypnotics) and average length of sleep the previous month along with the variables in Model 1. OR for medicines taken were adjusted by sleep quality and average length of sleep during the previous month in addition to the variables included in Model 1 (Model 3). OR for average length of sleep during the past month were calculated and adjusted for rating of sleep quality, medicines taken, and the variables in Model 1 (Model 4).
RESULTS
One subject participated in this study twice and another subject was found to be 65.4 years old (i.e., over 65 years). These two subjects were excluded; as a result, data from 598 subjects were analyzed. Of the patients invited, 86.5% agreed to participate. The age and sex of enrolled patients and those who declined to participate were similar and differences between the two groups were not significant ( At the initial medical consultation, diseases of the respiratory system, including the common cold, with ICD-10 codes J00-J99 were most frequent (37.8%). Second and third in frequency were diseases of the circulatory system (I00-I99) and diseases of the musculoskeletal system and connective tissue (M00-M99) (12.4% and 12.2%, respectively). Endocrine, nutritional, and metabolic diseases (E00-E90) and diseases of the digestive system (K00-K93) comprised 10.2% and 7.5%, respectively. No subjects had psychotic symptoms or dementia. Table 1 shows the characteristics of depressive and non-depressive subjects.
A total of 153 subjects (25.6%) were assessed as having depression. Two hundred and forty of the 598 subjects had a PSQI score > 5; namely, 40.1% of subjects were assessed as having insomnia. Only 25 (10.4%) of the 240 insomnia subjects complained about insomnia to physicians.
The highest LR+ was observed for a combination of three insomnia symptoms: 'difficulty falling asleep within 30 min ≥3 times/week,' 'very bad sleep quality,' and 'wake up in the middle of the night or early morning ≥3 times/week' ( Table 2 ). The combination of the former two (LR+ = 20.36) Among 550 subjects without any treatment history of psychiatric illnesses, similar calculations as those in Table 3 As a significant moderate correlation was observed between 'wake up in the middle of the night or early morning' and 'rating of sleep quality' (Spearman's correlation coefficient of r = 0.40, P < 0.001), these correlated variables were not included as explanatory variables simultaneously in calculations of adjusted OR.
SDS and POMS scores showed moderate correlation with statistical significance (Spearman's correlation coefficient of r = 0.49, P < 0.001).
DISCUSSION
Our investigation is unique because the study subjects were enrolled at internal medicine clinics, which are the main providers of primary care in Japan, at the time of the initial medical consultation. This cross-sectional study in which information on exposure and outcome are collected at the same time is similar to the situation faced by physicians who must collect information at the initial medical consultation and diagnose their patients on the same day. In general, tests with >10 for LR+ and <0.1 for LR− are associated with few false positives and few false negatives, respectively. 29 If patients report very good sleep quality, physicians may rule out depression at an early stage. If patients report very bad sleep quality with frequent difficulty falling asleep, a long time needed to fall asleep, or waking up frequently in the middle of the night or early morning, physicians should consider the possibility of depression.
In addition, deep-rooted stigma in society may make it difficult to discuss depression routinely in primary care settings. Lasalvia et al. reported that 79% of 1082 subjects with depression had experienced discrimination in daily life and 405 (37%) subjects had stopped themselves from initiating a close personal relationship out of fear of discrimination. 6 According to a survey that assessed depression label avoidance by asking participants about the degree to which they would accept a depression label from their primary care physician, 5.5% of patients reported they would 'disagree' and 2.4% of patients would 'strongly disagree' with a depression 7 Because of such a stigma, sleep status may be much easier for physicians and patients to discuss than depressive mood.
We investigated the relation between insomnia and depression, including dose-response relations. A multivariate analysis was conducted to control for confounding factors that could influence the association between insomnia and depression. 30 Subjects were restricted to new patients, because the effect of chronic disease under treatment, hypnotics, and relationship with the physician were minimized. Additionally a modified depression scale was employed that excluded two sleep-related items to avoid overestimating the association of insomnia with depression. 13 Although 'I get tired for no reason' does not always indicate insomnia, patients with insomnia often complain about fatigue. In the modified SDS described in Methods and Results, two items, 'I have trouble sleeping through the night' and 'I get tired for no reason,' were excluded. When additional analyses were conducted using the POMS and a modified SDS excluding only one item, 'I have trouble sleeping through the night,' most of the insomnia symptoms in Table 3 from the SDS may increase the probability of overestimation of the relation between insomnia and depression compared with the modified SDS that excluded two items. In other words, exclusion of two items from the SDS offered more strict conditions to show the relation between insomnia and depression than exclusion of only one item, and was more likely to prevent overestimation. Even after these analyses, consistently significant and remarkable associations with depression were observed for sleep quality, weekly frequency of difficulty falling asleep, and weekly frequency of waking up in the middle of the night or early morning, and the dose-response relationships were significant. In short, the more severe these three insomnia symptoms were, the higher the probability of depression.
In fact, few patients consult their physician about sleep problems. In this study, only 10.4% of insomniac subjects with PSQI > 5 complained about insomnia to their physician. Subjects may have thought that their sleep problems were not relevant or not as important as other health problems. Therefore, it is important for physicians to ask about sleep quality, difficulty falling asleep, and waking up in the middle of the night or early morning.
Our findings are consistent with the results of previous investigations. Kaneita et al. performed a cross-sectional study among 24 686 community residents. 8 They reported that difficulty initiating sleep, difficulty maintaining sleep, and early morning awakening were independently associated with depression. Yokoyama et al. conducted a crosssectional analysis and reported that depression was significantly associated with early morning awakening and difficulty initiating sleep among elderly people aged 65 years or older. 12 The present study assessed insomnia using selfadministered questionnaires. Szklo-Coxe et al. suggested that polysomnographic markers correspond to self-reported sleep status. 13 They reported that depression risks were increased by insomnia assessed by both polysomnography markers and self-reported symptoms among people aged 33-71 years.
In the present investigation, 153 subjects (25.6%) were assessed as having depression, a prevalence similar to that seen in previous studies. Zung et al. investigated 1537 subjects using the SDS in family practice and reported that the prevalence of depression in black and white subjects aged 35-64 years ranged from 19.0% to 23.6% and from 19.3% to 30.1%, respectively. 4 According to a cross-cultural survey, the Japanese version of the SDS was able to differentiate depressive disorders and normal subjects as well as the original SDS. 31 In our investigation, 57.0% of subjects showed an SDS index of 50 or higher. A similar prevalence of depression with an SDS index of 50 or more was reported among 57.1% of new internal medicine patients in the Chugoku district, Japan. 32 However, the prevalence of depression investigated by self-administered questionnaire among primary care patients varies from 5.5% to 64% depending on diagnostic criteria, threshold, and differences in target population. 3 In addition, the treatment rate in Japan was considerably lower than that among other developed countries and it was reported that three-quarters of patients with a serious-to-moderate mental disorder failed to receive treatment. 33 If the definition of depression in our study defined by only SDS had included too many non-depressed subjects, such as those suffering from neuroses or personality disorders, the result of the study might have been strongly influenced by non-depression. Therefore, to reduce false positives for depression, we employed both the SDS and the POMS to define depression.
Although depression in this study may have included non-depression, which did not fully correspond to the DSM-5, 34 we succeeded in eliminating observer bias introduced by several interviewers for diagnosis. The SDS and POMS, which are widely used for clinical and research purposes, 3, 4, 13, 18, 23, 35, 36 enabled us to assess all the subjects using consistent criteria without observer bias, which can cause unexpected over-or under-estimation of the relation between insomnia and depression. Self-reported information would seem to be advantageous for this study, which did not include psychotic or dementia patients whose ability to report their condition (e.g., poor sleep, depressive mood, and so on) may be impaired. 37 Some limitations of our investigation are as follows. First, the number of enrolled subjects was not very large; despite limited resources, we wanted to obtain complete datasets from all enrolled subjects because excluding subjects with missing data from multivariate analyses can derive biased results. The number of subjects analyzed who had not received psychiatric treatment(s) or diagnoses (diagnosis) was 550, despite the fact that no data were missing. After exclusion of 48 subjects, the OR for these subjects without mental disorder(s) showed wider CI and less precise point estimates of OR than those in Table 3 , 38 and this tendency toward wider CI and less precise point estimates was especially notable in the categories of 'quality of sleep' and 'medicine taken.' In addition, this study was not a nationwide multicenter study but was conducted at only three clinics located in Fuji City, which is an industrial city with a population of 250 000. Further, sleep status and depressive symptoms were investigated only by selfadministered questionnaires and physician questionnaires. Nevertheless, we accomplished our aim by identifying the subjective insomnia symptoms most related to depression in primary care settings.
The present results must be interpreted carefully. The findings may not be generalizable beyond middle-aged primary care patients. Further studies using different methods in different locations are needed to clarify the association of insomnia and depression in the primary care setting.
Conclusion
Signs of depression may often go undetected in the primary care setting, especially during initial consultations. The present study found that inquiring about the weekly frequency of difficulty 'falling asleep within 30 min' and 'waking up in the middle of the night or early morning,' and 'sleep quality' may be a useful way for primary care physicians to identify possible depression.
